Innate differences in tumour necrosis factor (TNF) production
Introduction
Tumour necrosis factor (TNF), a pro-inflammatory cytokine plays a pivotal role in regulation of immune responses. 1 Upon stimulation, cells of the immune system release TNF, whereas in resting conditions almost no TNF can be assessed. 2, 3 Many studies have investigated the relation between TNF and diseases that are based on an inflammatory etiology. 4, 5 The gene encoding TNF is located within the human leukocyte antigen (HLA) class III region, a region which is positioned between the HLA class I and class II region, and is approximately 750 kilobases (kb) in size. About 40% of the genes that are encoded within the HLA-region are involved in immune processes. 6 Owing to the location of the TNF gene within the HLA-region, the relations between HLA-haplotypes and TNF production have been investigated. So far, conflicting outcomes have been reported. 7 Ten single nucleotide polymorphisms (SNPs) have been observed in the TNF promoter region, one cytosine (C)-insertion polymorphism in the first exon of the TNF gene, and two SNPs in the first intron of the TNF gene. [8] [9] [10] [11] Therefore, various studies tried to determine whether these polymorphisms are associated with levels of TNF production, disease susceptibility and/or In a previous study we have identified that an innate high production of TNF combined with low production of interleukin-10 (IL-10) is a risk factor for relapse-onset multiple sclerosis (MS). 18 It has been presented that the absence of allele 107 of the TNFa microsatellite is associated with increased susceptibility for (relapse-onset) MS. 19, 20 Others reported that allele TNFa*107 is associated with decreased TNF production. 7 To date, association studies on TNF polymorphisms and MS reported inconclusive outcomes. 19, [21] [22] [23] [24] [25] [26] [27] In this study we tested whether endotoxin-induced TNF production and alleles of TNFa microsatellite, TNF single nucleotide G to A polymorphisms at positions +489, −238, −308 and −376 (relative to the transcription initiation site) were related. We also estimated the association between HLA-DR haplotypes and TNF production.
Results
Thirteen alleles with sizes ranging between 97 and 121 base pair (bp) were observed at the highly polymorphic TNFa locus (Table 1) . Using the Kruskall-Wallis test, no association was observed between the various alleles of the TNFa microsatellite and endotoxin-induced TNF production (P = 0.22; see Figure 1 ). Also, there was no significant difference between TNFa*107 carriers and non-carriers, ie median TNF production among TNFa* 107 carriers (n = 22) was 17880 pg/ml, whereas TNFa*107 non-carriers (n = 107) had a median TNF production of 15259 pg/ml (P = 0.15). Since non-carriership of allele TNFa*107 and carriership of HLA-DR2 have both been associated with susceptibility for relapse-onset MS, we Median TNF production in pg/ml with 25th and 75th percentiles assessed in healthy individuals.
Figure 1
Mean production of TNF in whole blood samples stimulated with 1000 ng/ml endotoxin in relation to alleles of TNFa microsattelite estimated in healthy individuals. Big bar represents mean overall TNF production.
tested whether individuals who were non-carrier of TNFa*107 and carrier of HLA-DR2 (n = 36) differed in TNF production as compared with other individuals (n = 93). Median endotoxin-induced TNF production (15654 pg/ml vs 15878 pg/ml) was not significant different between these two groups (P = 0.63).
Using Mann-Whitney test no association was observed between carriership of TNF single nucleotide G→A polymorphisms at positions +489, −238, −308, and −376 and TNF production (all P Ͼ 0.1, see Table 2 ).
Carriership of HLA-DR2 was not associated with TNF production (TNF production among HLA-DR2-carriers (n = 42) 16535 pg/ml vs 15553 pg/ml among DR2-noncarriers (n = 87); P = 0.99; see Figure 2 ). Similar results were obtained among 39 persons with systemic lupus erythematosus, there was no association between the HLA-DR haplotypes and TNF production (KruskallWallis test: P = 0.76). In this group HLA-DR2 carriers estimated a median production of 16606 pg/ml compared with 15962 pg/ml among HLA-DR2-non-carriers (P = TNF production is presented as median with 25th and 75th percentiles. TNF production was assessed in whole blood samples upon stimulation with 1000 ng/ml endotoxin. P-value was determined by Mann-Whitney test.
Figure 2
Mean production of TNF in whole blood samples stimulated with 1000 ng/ml endotoxin among HLA-DR2-carriers and HLA-DR2-non-carriers estimated in healthy individuals.
0.78), and HLA-DR3-carriers revealed a median production of 16875 pg/ml compared with 15697 pg/ml among HLA-DR3 non-carriers (P = 0.91).
Discussion
The aim of present study was to estimate whether endotoxin-induced TNF production in whole blood samples and alleles of the TNFa microsatellite, TNF single nucleotide polymorphisms at positions −376, −308, −238 and +489, or HLA-DR haplotypes were related. In the present study we could not show an association. Levels of TNF production upon stimulation with endotoxin can differ up to 10-fold between individuals. [28] [29] [30] A previous study showed that these differences are mainly determined by heritable factors. Comparing the correlation of TNF production among monozygotic twins and other siblings revealed that the heritability of endotoxininduced TNF production in whole blood samples was 0.60. 29 Outcomes of the numerous studies whether poly-27 morphisms in or near TNF genes do underlie these variations are conflicting. 15, 31 The data presented suggest that the genes or polymorphisms investigated do not determine the levels of endotoxin-induced TNF production in whole blood samples.
Studying in too small sample sizes can explain lack of association. The presented study was performed in 129 healthy individuals, the study that showed an association between TNF production and alleles of the TNFa microsatellite was performed in 75 individuals. 7 Most studies that report an association between carriership of −308A and endotoxin-induced TNF production had smaller numbers of −308AG (n Ͻ 20) and −308GG (n Ͻ 45) carriers as determined in this study (−308AG n = 43; −308GG n = 86). 15 It has been reported that beside the number of individuals studied the concentration of endotoxin (LPS) used might determine significant or nonsignificant findings. We used a concentration of endotoxin (1000 ng/ml). Also, stimulating whole blood samples, monocytes only, or peripheral blood mononuclear cells (PBMCs) may determine the outcome. Therefore, we conclude that the polymorphsisms studied are not related to differences in TNF production stimulated with 1000 ng/ml endotoxin in whole blood samples.
Since we have shown previously that both high innate TNF production and a low frequency of allele 107 of the TNFa microsatellite are associated with increased susceptibility for relapse-onset MS, 18, 20 it might be of interest to test whether these two risk markers are related. Especially, since it has been reported that carriership of TNFa*107 and decreased TNF production are associated. 7 It has been presented by others that a lower frequency of allele 107 of the TNFa microsatellite is present among patients with MS who are non-carrier of HLA-DR2. 19 In our hands, estimating both determinants in healthy subjects revealed that they were not related.
Since the gene encoding TNF is located within the HLA class III region and TNF and HLA are both involved in inflammatory processes, studies have been focused on TNF production and HLA-haplotypes. Although conflicting results have been reported, some studies revealed an association between HLA-DR haplotypes and TNF release. 7, 32 A study reported that T-cell lines specific for myelin basic protein or tetanus toxoid from HLA-DR2 carriers secreted more TNF than HLA-DR2 non-carriers. 33 However, others reported a lower spontaneous release of TNF by PBMCs from HLA-DR2 carriers compared with HLA-DR2 non-carriers. In the same study the HLA-DR3 haplotype was related to increased TNF production. 34 Using several stimuli, it has been reported that peripheral blood lymphocytes (PBL) of HLA-DR3 carriers produced more TNF than HLA-DR3 non-carriers. 28 In the present study and in previous reports by our group, 18 ,32 we could not observe an association between endotoxin-induced TNF production in whole blood cultures and HLA-DR haplotypes, including HLA-DR2 and HLA-DR3.
In summary, we conclude that the TNFa microsatellite, TNF single nucleotide polymorphisms at position +489, −238, −308, and −376 (relative to the transcription start site), and HLA-DR haplotypes do not determine endotoxin-induced TNF production in whole blood samples.
Genes and Immunity

Methods
Study design
The method how blood samples and data were collected have been described in detail elsewhere. 18, 35 To estimate the relation between TNF production upon stimulation with endotoxin and genetic markers, we included control subjects that were enrolled for a previous study. Persons were included after approval by the Medical Ethics Board of the Leiden University Medical Center, Leiden, The Netherlands. The subjects studied were 129 healthy individuals (57 males and 72 females; mean age 47 ± 14 years) and belonged to 54 families. 17 Individuals with current infectious diseases were excluded, since infections might determine levels of cytokine production. All persons were Caucasian and of Dutch ancestry. 35 The TNFa microsatellite, TNF single nucleotide polymorphisms and HLA-DR2 typing were all assessed in this series.
In a second analysis, to support the hypothesis that inherited differences in endotoxin-induced TNF production are not regulated by genetic markers in or near the TNF gene we will also show data on the association between endotoxin-induced TNF production and other HLA-DR subtypes. These estimates were made in 39 persons (three males and 36 females; mean age 41 ± 15 years) with systemic lupus erythematosus that were enrolled for a previous study. These persons had similar estimates of TNF production compared to the control subjects. 35 
Whole blood stimulation
The methods by which whole blood samples were obtained and stimulated have been described previously. 30 Briefly, blood samples were taken between 8 and 11 am to minimize the influence of circadian rhythms. Blood was collected in pyrogen-free heparinized tubes (Endotube  , Chromogenix, Mö lndal, Sweden) and stimulated with 1000 ng/ml endotoxin during 4 h. In addition, unstimulated baseline samples were obtained to act as a control for contamination. TNF production was measured using ELISA. The detection limit was 4 pg/ml. Due to technical errors, no TNF production was obtained from seven subjects, and thus they were excluded from further analysis. The ELISA's were done blinded to the source of material at a random order. In a previous study, we showed that sex or age did not underlie differences in cytokine production.
30
Selection and amplification of TNFa microsatellite TNFa microsatellite, a highly polymorphic marker, is located telomeric of TNF gene in vicinity of lymphotoxin ␣ (LT␣). Detailed information on this microsatellite has been published elsewhere. 36, 37 Peripheral blood cells were sodium dodecyl sulphatelysed and treated with proteinase-K. DNA was isolated by phenol-chloroform exctraction. 38 Amplification was carried out by fluorescent-primer polymerase chain reaction (PCR) in a total reaction volume of 25 L containing approximately 50 ng of genomic DNA, 12.5 pmol of forward and reverse primers, 200 M of dNTP's (Pharmacia Biotech, Uppsala, Sweden), 5% (v/v) glycerol, and 2.5 units of Taq polymerase (Amplitaq  , Perkin Elmer, Foster City, CA, USA). Amplification buffer contained 50 mM KCl, 1.5 mM MgChl 2 , 10 mM Tris-HCl at pH 8.4 (room temperature) and 0.06 mg/ml bovine serum albumin. PCR was performed at an annealing temperature of between 58 to 68°C using a Peltier Thermal Cycler (PTC-200, MJ-Research, MA, USA). Touchdown PCR was utilized in order to increase the specificity of annealing during the first cycles. To analyze the number of base pairs of each allele, PCR products were loaded onto a denaturing sequencing gel (Reprogel  High Resolution, Pharmacia Biotech) in an Automated Laser Fluorescence-DNA sequencer (ALF-express II  , Pharmacia Biotech). Electrophoresis (1500 V, 60 mA, 30 W at 55°C) and data collection were performed using ALF Manager software (Pharmacia Biotech). Data were analyzed using ALFwin Fragment Analyzer 1.01 software (Pharmacia Biotech). Accurate allele assignment was performed using Cy5-labelled internal size markers and running external allelic ladders composed of PCR products of Epstein-Barr virus-transformed lymphoblastoid cell lines for each microsatellite. 39 Analysis of samples was performed using a 96-lane ABI 377-DNA sequencer (Applied Biosystems, CA, USA). Data were analyzed using Genescan 3.1 and Genotyper 2.0 software (Applied Biosystems). Accurate allele sizing was achieved using Genescan-ROX 400HD internal size markers and external allelic markers were run as described above.
TNF single nucleotide polymorphisms and HLA-DR typing
Typing for the TNF single nucleotide polymorphisms −376, −308, −238, and +489 was performed by PCR on a Perkin Elmer thermal cycler GeneAmp 9600 (PE-Cetus, Norwalk, CA, USA). For detection of TNF single nucleotide polymorphisms, PCR was followed by restriction enzyme digestion. For −376 (G→A) a 186 bp fragment was amplified with forward primer (5Ј-CTAGTTCTATC TTTTTCCTGCGTCCTGTCTGGAT-3Ј) and reverse primer (5Ј-ATCCTCCCTGCTCCGATTCC-3Ј). The PCR conditions were as follows: 10 min at 95°C, followed by 30 cycles of 30 s at 95°C, 30 s at 60°C and 30 s at 72°C. A final extension was performed at 72°C for 10 min. PCR products were digested by incubation with FokI (New England Biolabs, MA, USA) at 37°C for 3 h. For −308 (G→A) a 147 bp fragment was amplified with forward primer (5Ј-GAGGCAATAGGTTTTGAGGGCCAT-3Ј) and reverse primer (5Ј-GGGACACACAAGCATCAAG-3Ј). The PCR conditions were similar as described above, only the number of cycles was increased to 35. PCR products were digested by incubation with NcoI (New England Biolabs) at 37°C for 2 h. For −238 (G→A) a 165 bp fragment was amplified with forward primer (5Ј-AAACAGACCACAGACCTGGTC-3Ј) and reverse primer (5Ј-AAGGATACCCCTCACACTCCCCATCCTCCCGGA TC-3Ј). PCR conditions were similar as for −308. PCR products of −238 were digested by incubation with BamHiI (Gibco BRL, Life Technologies, MD, USA) at 37°C for 2 h. For +489 (G→A) a 550 bp fragment was amplified with forward primer (5Ј-GGAGAGAAGCAACTACAGAC-3Ј) and backward primer (5Ј-CACACTTAGTGAGCACC TTC-3Ј). The PCR conditions were as follows: 10 min at 95°C, followed by 35 cycles of 30 s at 95°C, 30 s at 58°C and 30 s at 72°C. A final extension was performed at 72°C for 10 min. PCR products were digested by incubation with TaiI (MBI Fermentas) at 65°C for 3 h. The restriction fragments (151 and 35 bp for −376 G and 186 bp for −376 A; 126 and 21 bp for −308 G and 147 bp for −308 A; 123 and 42 bp for −238 G and 165 bp for −238 A; 281, 159 and 111 bp for +489 G and 392 and 159 bp for +489 A) were separated on 3% agarose gel and visualized after ethidium bromide staining. DRB1*15 typing, an associative marker for HLA-DR2, was performed using in-house-designed sequencespecific primers that amplify DRB1*1501, 1503, 1504, 1506, and 1507. 40 All individuals with systemic lupus erythematosus were typed for their HLA-haplotypes as described previously. 41 
Statistical analysis
Determining whether alleles of the TNFa microsatellite were associated with differences in endotoxin-induced TNF production the Kruskall-Wallis test was performed, which does not assume an underlying distribution of data. Significance was defined as a probability value less than 0.05. In addition, the median TNF production was compared between TNFa*107 carriers and TNFa*107 noncarriers using Mann-Whitney test.
Studying whether carriership of TNF single nucleotide G→A polymorphisms at positions +489, −238, −308, and −376 relative to the transcription start site were related to TNF production, median TNF production of heteroand homozygous carriers of polymorphisms (AG and AA, respectively) were compared with homozygous wildtype carriers (GG) using Mann-Whitney test.
Estimating whether HLA-DR2 carriership was related to TNF production, HLA-DR2-carriers were compared with HLA-DR2-non-carriers using Mann-Whitney test. In addition, the association between various HLA-DR haplotypes and TNF production was studied among persons with systemic lupus erythematosus using KruskalWallis test.
